Ocuvite vs PreserVision

In order to support and maintain the health of your vision, you should make sure that you get enough vitamins and other nutrients that are needed by your eyes. Without sufficient vitamins and other nutrients, the eyes will not be able to function properly. One of the most common eye problems that people encounter as they age is age-related macular degeneration (AMD). This condition can be treated by several supplements on the market that aim to supply the much needed nutrients to the eyes. Two of the most popular eye supplements on the market right now are Ocuvite and PreserVision, both made by Bausch+Lomb. So, what is the difference between Ocuvite vs PreserVision?

Functions and Benefits
First of all, Ocuvite and PreserVision are produced by the manufacturer for different purposes. Ocuvite has been designed as a regular daily supplement for the health of the eyes. It aims to fulfill the daily nutritional requirement of the eyes. It is not specifically formulated to treat any specific disease. It is to prevent a variety of eye-related problems, although it does not necessarily prevent AMD. Compared to other products on the market, Ocuvite comes with more specific nutrients, vitamins, and minerals.

On the other hand, PreserVision is specifically crafted to treat age-related macular degeneration (AMD), which is a medical condition which may lead to blurred or no vision in the center of the visual field of view. AMD is caused by damage to the retina’s macula. Early on, AMD often does not show any symptom. However, over time, the sufferer may experience a gradual worsening on one or both eyes. Although it does not result in complete blindness, the loss of the central vision may hinder your ability to write, read, drive, and recognize faces. It may also cause visual hallucinations that are not related to any mental illness. Various researches have shown that the supplementation of lutein and zeaxanthin may slow down the worsening, but there is no known way to prevent the disease in the first place.

Different Product Varieties
Next, you need to know that Ocuvite and PreserVision are available in several different formulations. The general eye health supplement Ocuvite is available in three different formulas: Ocuvite with Lutein (contains 2 mg of Lutein per tablet), Ocuvite Lutein & Zeaxanthin (contains 6 mg of a combination of Lutein and Zeaxanthin per tablet), and Ocuvite with Lutein, Zeaxanthin, and Omega-3 (5 mg of Lutein, 1 mg of Zeaxanthin, and 250 mg of Omega-3 per tablet).

On the other hand, PreserVision is available in four different formulas: PreserVision with Lutein (10mg of FloraGlo Lutein), PreserVision AREDS soft gels, PreserVision AREDS tablets, and PreserVision AREDS 2. You should know that the AREDS and AREDS 2 formulas are the complete formulas with Lutein and Zeaxanthin.

However, the AREDS 2 formula is the newest formula that has been optimized and has been proven to be more effective. Compared to Ocuvite, PreserVision AREDS 2 actually comes with similar ingredients. But it has different proportions to deliver more effective results on treating AMD.

Name OcuvitePreserVision
Key Features- Ocuvite Vitamin and Mineral Supplement for Adult's 50+ are vision and eye supplements that work to improve your eye's health and vision - Bausch and Lomb's Ocuvite Vitamin and Mineral Heath Supplement is a unique formula to help replenish vital eye nutrients that can deteriorate as you age- PreserVision is the #1 recommended brand by eye doctors for people with moderate-to-advanced age-related macular degeneration. Brought to you by Bausch + Lomb — the leader in AREDS eye vitamins -The exact nutrient formula recommended by the National Eye Institute which includes lutein and zeaxanthin

Best Offer*Save Money Please click hereSave Money Please click here

If you are looking for a general eye health supplement, Ocuvite is sufficient. However, if you specifically need something to treat AMD, you have to choose PreserVision AREDS 2 for the best results.

Post A Comment

Your email address will not be published. Required fields are marked *